At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
RGC Regencell Bioscience Limited
Post-Mkt 04-24 17:52:06 EDT
27.49
-0.82
-2.90%
盘后27.13
-0.36-1.31%
17:03 EDT
High28.88Low27.00Vol61.04K
Open28.70D1 Closing28.31Amplitude6.62%
Mkt Cap13.59BTradable Cap506.72MTotal Shares494.49M
T/O1.67MT/O Rate0.33%Tradable Shares18.43M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Regencell Bioscience replaces auditor Marcum Asia with HTL International
Reuters  ·  04-18
Regencell Bioscience replaces auditor Marcum Asia with HTL International
Assessing Regencell Bioscience Holdings (NasdaqCM:RGC) Valuation After New Equity Offering Plans
Simply Wall St.  ·  04-07
Assessing Regencell Bioscience Holdings (NasdaqCM:RGC) Valuation After New Equity Offering Plans
Regencell Bioscience falls -7.1%
TIPRANKS  ·  04-07
Regencell Bioscience falls -7.1%
VinFast, Alcoa, And Regencell Are Among the Top 10 Large-Cap Gainers Last Week (March 30-April 2): Are the Others in Your Portfolio?
Benzinga_recent_news  ·  04-05
VinFast, Alcoa, And Regencell Are Among the Top 10 Large-Cap Gainers Last Week (March 30-April 2): Are the Others in Your Portfolio?
Regencell Bioscience falls -9.5%
TIPRANKS  ·  04-03
Regencell Bioscience falls -9.5%
RGC Resources Extends Private Shelf Facility Borrowing Capacity
TIPRANKS  ·  04-02
RGC Resources Extends Private Shelf Facility Borrowing Capacity
Regencell Bioscience rises 23.9%
TIPRANKS  ·  04-01
Regencell Bioscience rises 23.9%
RGC Resources Keeps Quarterly Dividend at $0.2175 a Share, Payable on May 1 to Shareholders of Record on April 17
MT Newswires Live  ·  04-01
RGC Resources Keeps Quarterly Dividend at $0.2175 a Share, Payable on May 1 to Shareholders of Record on April 17
Press Release: RGC Resources, Inc. Declares Quarterly Dividend
Dow Jones  ·  04-01
Press Release: RGC Resources, Inc. Declares Quarterly Dividend
Regencell Bioscience files sales agreement with Univest Securities for equity distribution program
Reuters  ·  03-30
Regencell Bioscience files sales agreement with Univest Securities for equity distribution program
Regencell Bioscience files for up to USD 500 million at-the-market share offering
Reuters  ·  03-30
Regencell Bioscience files for up to USD 500 million at-the-market share offering
Regencell Bioscience Holdings Ltd - May Offer Ordinary Shares up to $500 Mln Through Univest - SEC Filing
THOMSON REUTERS  ·  03-30
Regencell Bioscience Holdings Ltd - May Offer Ordinary Shares up to $500 Mln Through Univest - SEC Filing
Regencell Bioscience Holdings Ltd Files for Common Stock Shelf; Size Not Disclosed - SEC Filing
THOMSON REUTERS  ·  03-30
Regencell Bioscience Holdings Ltd Files for Common Stock Shelf; Size Not Disclosed - SEC Filing
Regencell Bioscience falls -8.7%
TIPRANKS  ·  03-24
Regencell Bioscience falls -8.7%
RGC Resources Extends Revolving Credit Facility with Pinnacle Bank
TIPRANKS  ·  03-20
RGC Resources Extends Revolving Credit Facility with Pinnacle Bank
Regencell Bioscience rises 15.4%
TIPRANKS  ·  03-19
Regencell Bioscience rises 15.4%
Regencell Bioscience Shares Surge Over 16% Despite No Approved Products
Stock News  ·  03-18
Regencell Bioscience Shares Surge Over 16% Despite No Approved Products
Regencell Bioscience Director William Wing Yan Lo Files Initial Beneficial Ownership Statement
Reuters  ·  03-18
Regencell Bioscience Director William Wing Yan Lo Files Initial Beneficial Ownership Statement
Regencell Bioscience Holdings Ltd. Director Margaret Hoor Han Lo Files Initial Beneficial Ownership Statement
Reuters  ·  03-18
Regencell Bioscience Holdings Ltd. Director Margaret Hoor Han Lo Files Initial Beneficial Ownership Statement
Regencell Bioscience Holdings files Form 3 for COO and Chief Strategy Officer James Wai Hong Chung
Reuters  ·  03-18
Regencell Bioscience Holdings files Form 3 for COO and Chief Strategy Officer James Wai Hong Chung

Introduction

Company Name.
Regencell Bioscience Limited
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Issue price:
--